— Know what they know.
Not Investment Advice
Also trades as: 0013.HK (HKSE) · $vol 14M · HCM.L (LSE) · $vol 0M · HMDCF (OTC) · $vol 0M

HCM NASDAQ

HUTCHMED (China) Limited
1W: +1.9% 1M: +17.9% 3M: +21.9% YTD: +4.0% 1Y: -11.0% 3Y: -14.9% 5Y: -61.2%
$14.20
-0.37 (-2.54%)
 
Weekly Expected Move ±6.5%
$12 $13 $14 $15 $16
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 66 · $2.5B mcap · 170M float · 0.039% daily turnover · Short 32% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$18
Low
$32
Avg Target
$45
High
Based on 2 analysts since Jul 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 1Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$25.83
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-09 Stifel Nicolaus James Condulis Initiated $45 — +230.4% $13.62
2026-09-03 Daiwa Jing Yang Initiated $18 — +31.0% $14.12
2026-07-23 Goldman Sachs — Initiated $14 — +25.9% $11.12
2026-05-28 Morgan Stanley — $18 $14 -4 +21.1% $11.23
2024-05-14 Morgan Stanley Jack Lin Initiated $18 — -18.4% $21.45

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 02, 2026
DCF
1
ROE
2
ROA
4
D/E
2
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HCM receives an overall rating of B-. Strongest factors: ROA (4/5), P/B (4/5). Areas of concern: DCF (1/5), ROE (2/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-08-03 B+ B-
2026-07-09 C- B+
2026-05-04 D+ C-
2026-04-01 C- D+
2026-03-12 A- C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 44 Grade C
Profitability
50
Balance Sheet
94
Earnings Quality
4
Growth
51
Value
88
Momentum
34
Safety
80
Cash Flow
18
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HCM scores highest in Balance Sheet (94/100) and lowest in Earnings Quality (4/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.35
Safe Zone
Piotroski F-Score
6/9
✓ ✗ ✓ ✗ ✓ ✓ ✓ ✓ ✗
Beneish M-Score
-2.48
Unlikely Manipulator
Ohlson O-Score
-10.26
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 61.0/100
Trend: Deteriorating
Earnings Quality
25/100
OCF/NI: -0.13x
Accruals: 35.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HCM scores 3.35, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HCM scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HCM's score of -2.48 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HCM's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HCM receives an estimated rating of BBB+ (score: 61.0/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). HCM's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
155.01x
PEG
-1.61x
P/S
4.54x
P/B
1.97x
P/FCF
-24.86x
P/OCF
—
EV/EBITDA
56.56x
EV/Revenue
1.07x
EV/EBIT
-225.51x
EV/FCF
-7.89x
Earnings Yield
25.07%
FCF Yield
-4.02%
Shareholder Yield
0.00%
Graham Number
$20.94
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 155.0x earnings, HCM is priced for high growth expectations. An earnings yield of 25.1% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $20.94 per share, suggesting a potential 47% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.878
NI / EBT
×
Interest Burden
-202.710
EBT / EBIT
×
EBIT Margin
-0.005
EBIT / Rev
×
Asset Turnover
0.369
Rev / Assets
×
Equity Multiplier
1.490
Assets / Equity
=
ROE
46.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HCM's ROE of 46.6% is driven by Asset Turnover (0.369), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$103.85
Price/Value
0.10x
Margin of Safety
89.64%
Premium
-89.64%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with HCM's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $103.85, HCM appears undervalued with a 90% margin of safety. The adjusted fair P/E of 38.5x compares to the current market P/E of 155.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$14.20
Median 1Y
$11.14
5th Pctile
$3.87
95th Pctile
$32.46
Ann. Volatility
62.4%
Analyst Target
$25.83
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,796
-0.8% YoY
Revenue / Employee
$306,215
Rev: $549,962,669
Profit / Employee
$255,077
NI: $458,117,403
SGA / Employee
$57,517
Avg labor cost proxy
R&D / Employee
$91,397
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
ROE -48.7% -32.9% -30.8% -29.2% -37.7% -35.5% -46.3% -55.4% -35.0% -3.7% 5.3% 15.0% 3.9% -5.5% -0.3% 5.1% 25.6% 47.4% 46.4% 46.6% 46.61%
ROA -30.1% -24.3% -21.6% -20.5% -24.5% -25.7% -30.8% -36.8% -22.2% -2.4% 3.1% 8.7% 2.3% -3.3% -0.2% 3.0% 16.6% 30.7% 31.1% 31.3% 31.28%
ROIC -2.6% -2.9% -20.4% -1.8% 1.8% 5.6% -38.7% -62.7% 7.7% 2.3% 48.5% -25.3% -1.8% -3.8% 3.9% -2.7% 77.1% 41.0% 46.3% 11.0% 10.99%
ROCE -45.1% -25.6% -27.8% -30.9% -41.7% -43.7% -58.4% -60.4% -26.5% -10.4% -4.6% 2.1% -5.8% -13.6% -9.2% -4.9% -2.2% -1.4% -0.8% -0.2% -0.18%
Gross Margin 20.4% 23.1% -56.5% 5.9% -57.9% 32.0% -68.9% -68.9% 60.9% 60.9% -9.3% -9.3% 41.1% 41.1% -17.4% -17.4% 39.7% 39.7% 17.0% 17.0% 17.01%
Operating Margin -77.5% -1.1% -92.9% 1.5% -97.4% -97.4% -94.0% -94.0% 21.0% 21.0% -30.6% -30.6% -9.0% -9.0% -5.0% -5.0% -1.3% -1.3% 0.3% 0.3% 0.31%
Net Margin -79.5% -1.0% -46.4% -19.3% -80.6% -80.6% -88.2% -88.2% 31.6% 31.6% -22.2% -22.2% 8.4% 8.4% 3.7% 3.7% 1.6% 1.6% 5.7% 5.7% 5.72%
EBITDA Margin -75.6% -1.0% -91.0% -65.5% -95.2% -47.6% -92.1% -92.1% 21.7% 21.7% -29.1% -29.1% -7.0% -7.0% -3.1% -3.1% 0.9% 0.9% 2.9% 2.9% 2.85%
FCF Margin -36.8% -42.4% -53.4% -56.0% -59.1% -55.3% -59.3% -67.9% -29.5% 0.3% 11.9% 22.3% 8.4% -10.7% -6.7% -2.8% -5.4% -8.2% -10.8% -13.6% -13.59%
OCF Margin -32.0% -37.7% -48.7% -51.7% -54.7% -49.5% -52.5% -59.4% -22.4% 6.3% 16.7% 26.2% 11.9% -7.7% -3.7% 0.1% -2.6% -5.4% -8.1% -10.9% -10.91%
ROE 3Y Avg snapshot only 18.70%
ROE 5Y Avg snapshot only -7.63%
ROA 3Y Avg snapshot only 12.65%
ROIC Economic snapshot only -0.17%
Cash ROA snapshot only -3.49%
NOPAT Margin snapshot only -0.42%
Pretax Margin snapshot only 96.44%
R&D / Revenue snapshot only 27.12%
SGA / Revenue snapshot only 15.85%
SBC / Revenue snapshot only 1.38%
Valuation
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
P/E Ratio -23.42 -26.45 -27.68 -27.93 -13.87 -6.77 -4.05 -5.65 -8.16 -70.72 80.94 30.63 99.70 -71.18 -1608.31 66.70 10.40 5.63 5.57 3.99 155.007
P/S Ratio 15.84 20.73 19.75 15.21 7.76 3.97 2.71 4.74 3.26 2.75 3.62 3.68 4.05 4.89 5.50 3.99 4.26 4.36 4.51 3.38 4.538
P/B Ratio 9.54 5.86 6.35 6.09 4.02 2.68 2.45 4.09 2.89 2.66 3.95 4.23 3.96 4.04 4.49 3.31 2.14 2.14 2.07 1.49 1.969
P/FCF -43.04 -48.87 -36.97 -27.18 -13.12 -7.19 -4.56 -6.98 -11.05 869.16 30.55 16.54 48.34 -45.72 -82.40 -144.32 -78.24 -52.89 -41.71 -24.86 -24.857
P/OCF — — — — — — — — — 43.66 21.64 14.08 34.03 — — 5063.06 — — — — —
EV/EBITDA -16.96 -19.00 -18.34 -15.66 -6.70 -3.54 -2.31 -4.75 -5.87 -13.87 -64.55 86.04 -53.05 -20.63 -37.61 -56.44 -70.00 -180.95 870.49 56.56 56.564
EV/Revenue 14.45 17.45 16.68 12.75 5.75 2.44 1.61 3.59 2.08 1.67 2.61 2.73 3.06 3.72 4.29 2.81 2.21 2.25 2.30 1.07 1.073
EV/EBIT -16.39 -18.54 -17.93 -15.33 -6.56 -3.46 -2.26 -4.65 -5.68 -12.74 -51.54 124.47 -43.29 -18.81 -32.36 -40.50 -42.89 -68.81 -119.02 -225.51 -225.507
EV/FCF -39.26 -41.14 -31.21 -22.78 -9.73 -4.42 -2.71 -5.29 -7.05 528.30 22.06 12.25 36.55 -34.78 -64.31 -101.52 -40.53 -27.29 -21.24 -7.89 -7.893
Earnings Yield -4.3% -3.8% -3.6% -3.6% -7.2% -14.8% -24.7% -17.7% -12.2% -1.4% 1.2% 3.3% 1.0% -1.4% -0.1% 1.5% 9.6% 17.8% 18.0% 25.1% 25.07%
FCF Yield -2.3% -2.0% -2.7% -3.7% -7.6% -13.9% -21.9% -14.3% -9.0% 0.1% 3.3% 6.0% 2.1% -2.2% -1.2% -0.7% -1.3% -1.9% -2.4% -4.0% -4.02%
Price/Tangible Book snapshot only 1.490
EV/Gross Profit snapshot only 3.788
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $20.94
Leverage & Solvency
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Current Ratio 2.63 4.40 3.89 3.89 3.18 3.18 2.37 2.37 3.20 3.20 2.72 2.72 2.81 2.81 2.83 2.83 4.65 4.65 5.64 5.64 5.644
Quick Ratio 2.53 4.30 3.77 3.77 3.03 3.03 2.21 2.21 3.04 3.04 2.60 2.60 2.68 2.68 2.70 2.70 4.51 4.65 5.50 5.50 5.496
Debt/Equity 0.09 0.04 0.04 0.04 0.00 0.00 0.04 0.04 0.05 0.05 0.12 0.12 0.12 0.12 0.12 0.12 0.08 0.08 0.07 0.07 0.075
Net Debt/Equity -0.84 -0.93 -0.99 -0.99 -1.04 -1.03 -0.99 -0.99 -1.05 -1.04 -1.10 -1.10 -0.97 -0.97 -0.99 -0.98 -1.03 -1.03 -1.02 -1.02 -1.017
Debt/Assets 0.05 0.03 0.03 0.03 0.00 0.00 0.03 0.03 0.03 0.03 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.05 0.05 0.05 0.054
Debt/EBITDA -0.17 -0.14 -0.14 -0.12 -0.00 -0.00 -0.07 -0.07 -0.16 -0.44 -2.67 3.24 -2.12 -0.80 -1.27 -2.86 -5.19 -12.48 61.87 8.96 8.962
Net Debt/EBITDA 1.63 3.57 3.38 3.03 2.33 2.21 1.57 1.51 3.34 8.95 24.86 -30.10 17.11 6.49 10.58 23.80 65.11 169.70 -839.25 -121.57 -121.569
Interest Coverage — — — — — — — — — — — — — — — — — — — — —
Equity Multiplier 1.62 1.29 1.39 1.39 1.49 1.49 1.69 1.69 1.66 1.66 1.75 1.75 1.70 1.70 1.68 1.68 1.44 1.44 1.38 1.38 1.377
Cash Ratio snapshot only 5.001
Cash to Debt snapshot only 14.564
FCF to Debt snapshot only -0.800
Defensive Interval snapshot only 3406.3 days
Efficiency & Turnover
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Asset Turnover 0.45 0.31 0.30 0.38 0.44 0.44 0.46 0.44 0.56 0.61 0.69 0.73 0.57 0.48 0.49 0.49 0.41 0.40 0.38 0.37 0.369
Inventory Turnover 17.40 16.14 13.75 14.72 15.33 16.31 13.33 14.62 12.43 11.77 10.56 10.13 10.52 10.24 10.68 11.15 11.69 23.62 10.38 8.74 8.736
Receivables Turnover 5.35 5.43 4.83 6.01 6.36 8.01 6.10 5.81 6.72 7.34 7.42 7.80 5.06 4.27 4.56 4.63 4.06 3.96 4.24 4.07 4.072
Payables Turnover 11.90 12.10 10.49 11.23 12.64 14.65 10.98 12.04 11.75 11.12 10.51 10.09 10.77 10.49 13.63 14.23 12.73 12.59 12.43 10.46 10.464
DSO 68 67 76 61 57 46 60 63 54 50 49 47 72 85 80 79 90 92 86 90 89.6 days
DIO 21 23 27 25 24 22 27 25 29 31 35 36 35 36 34 33 31 15 35 42 41.8 days
DPO 31 30 35 32 29 25 33 30 31 33 35 36 34 35 27 26 29 29 29 35 34.9 days
Cash Conversion Cycle 58 60 67 53 52 43 54 57 53 48 49 47 73 86 88 86 93 79 92 97 96.5 days
Fixed Asset Turnover snapshot only 5.928
Operating Cycle snapshot only 131.4 days
Cash Velocity snapshot only 0.404
Capital Intensity snapshot only 3.123
Growth (YoY)
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Revenue 26.6% 33.3% 44.1% 73.2% 60.6% 94.1% 74.4% 33.6% 67.2% 40.1% 44.1% 58.9% 4.6% -19.3% -22.2% -24.8% -14.9% -1.4% -6.7% -11.8% -11.78%
Net Income -58.5% -84.8% -81.1% -71.0% -32.8% -45.2% -63.3% -1.1% -19.4% 90.7% 1.1% 1.2% 1.1% -42.6% -1.1% -62.6% 7.6% 12.1% 222.1% 11.5% 11.48%
EPS -49.9% -72.6% -50.3% -44.5% -13.1% -25.7% -65.5% -1.1% -17.0% 90.9% 1.1% 1.2% 1.1% -41.7% -1.1% -63.5% 7.6% 12.1% 222.2% 11.5% 11.48%
FCF -50.6% -34.3% -1.4% -2.2% -1.6% -1.5% -93.7% -62.0% 16.6% 1.0% 1.3% 1.5% 1.3% -28.3% -1.4% -1.1% -1.6% 24.0% -51.3% -3.3% -3.33%
EBITDA -54.9% -70.7% -67.0% -69.6% -61.9% -45.9% -33.8% -24.2% 31.1% 75.6% 91.6% 1.1% 83.0% -20.8% -1.2% -2.2% 53.5% 93.2% 1.0% 1.3% 1.34%
Op. Income -60.1% -18.5% -7.0% 83.2% 70.0% 29.7% 33.1% -14.3% -4.2% 46.2% 79.5% 1.0% 85.4% -21.7% -1.0% -3.4% 38.1% 83.7% 86.4% 93.9% 93.95%
OCF Growth snapshot only -123.07%
Asset Growth snapshot only 36.28%
Equity Growth snapshot only 65.91%
Debt Growth snapshot only 5.22%
Shares Change snapshot only -0.03%
Growth (CAGR)
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Revenue 3Y -9.6% 0.8% 5.1% 12.5% 14.4% 25.0% 27.4% 37.2% 50.4% 53.6% 53.6% 54.3% 41.1% 29.9% 25.0% 16.9% 14.1% 3.7% 1.5% 1.8% 1.77%
Revenue 5Y 37.6% 21.7% 14.6% 12.8% 12.8% 12.4% 12.8% 7.9% 14.7% 22.7% 23.9% 24.8% 21.2% 17.1% 18.3% 25.3% 24.8% 23.6% 21.3% 19.5% 19.52%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — 0.0% 27.7% 33.5% 34.0% 25.0% 9.5% 13.3% — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 5.0% 30.1% 33.4% 37.1% 30.3% 34.1% 31.4% 30.3% 40.8% 35.2% 20.9% 20.9% 22.1% -0.3% -2.5% -2.5% 14.1% 14.1% 19.0% 19.0% 19.04%
Assets 5Y 16.5% 31.6% 32.0% 32.0% 28.2% 28.2% 11.5% 11.5% 16.8% 17.6% 17.2% 19.2% 18.5% 20.6% 22.9% 22.3% 30.7% 27.6% 19.1% 19.1% 19.12%
Equity 3Y -2.5% 31.6% 31.7% 36.4% 28.6% 32.0% 24.9% 28.4% 39.5% 31.7% 14.7% 14.7% 20.0% -9.1% -8.3% -8.3% 15.4% 15.4% 27.4% 27.4% 27.35%
Book Value 3Y -5.2% 27.2% 21.0% 25.4% 18.6% 21.7% 15.3% 18.6% 28.9% 21.9% 8.0% 8.6% 12.7% -14.1% -8.9% -8.9% 14.4% 14.4% 26.0% 26.0% 25.98%
Dividend 3Y — — — — — — — -11.6% -11.6% -11.4% -9.9% — — — — — — — — — —
Growth Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Revenue Stability 0.27 0.50 0.57 0.35 0.41 0.26 0.34 0.25 0.40 0.65 0.69 0.72 0.79 0.70 0.72 0.77 0.75 0.58 0.48 0.41 0.412
Earnings Stability 0.92 0.91 0.93 0.93 0.97 0.94 0.90 0.78 0.97 0.06 0.01 0.00 0.00 0.07 0.11 0.11 0.42 0.54 0.56 0.54 0.540
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.87 0.82 0.50 0.50 0.92 0.50 0.20 0.20 0.20 0.83 0.20 0.50 0.50 0.20 0.20 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — 0.09 0.00 — — 0.00 0.000
ROE Trend -0.07 0.12 0.09 0.11 0.11 -0.11 -0.36 -0.49 -0.01 0.27 0.47 0.61 0.36 0.16 0.28 0.34 0.36 0.43 0.35 0.28 0.280
Gross Margin Trend -0.19 -0.15 -0.11 0.24 0.03 0.15 0.17 -0.13 0.32 0.35 0.45 0.51 0.33 0.09 0.04 0.07 -0.09 -0.10 -0.03 0.05 0.052
FCF Margin Trend -0.15 -0.13 -0.22 -0.19 -0.25 -0.13 -0.16 -0.25 0.18 0.49 0.68 0.84 0.53 0.17 0.17 0.20 0.05 -0.03 -0.13 -0.23 -0.233
Sustainable Growth Rate — — — — — — — — — — -7.7% 15.0% 3.9% — — 5.1% 25.6% 47.4% 46.4% 46.6% 46.61%
Internal Growth Rate — — — — — — — — — — — 9.6% 2.4% — — 3.0% 19.9% 44.4% 45.2% 45.5% 45.52%
Cash Flow Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
OCF/Net Income 0.47 0.48 0.68 0.95 0.98 0.84 0.79 0.71 0.56 -1.62 3.74 2.18 2.93 1.12 10.96 0.01 -0.06 -0.07 -0.10 -0.13 -0.129
FCF/OCF 1.15 1.13 1.10 1.08 1.08 1.12 1.13 1.14 1.31 0.05 0.71 0.85 0.70 1.39 1.78 -35.08 2.09 1.52 1.34 1.25 1.246
FCF/Net Income snapshot only -0.160
OCF/EBITDA snapshot only -5.754
CapEx/Revenue 4.8% 4.7% 4.7% 4.2% 4.4% 5.8% 6.8% 8.4% 7.0% 6.0% 4.9% 3.9% 3.5% 3.0% 2.9% 2.8% 2.8% 2.8% 2.8% 2.7% 2.68%
CapEx/Depreciation snapshot only 1.129
Accruals Ratio -0.16 -0.13 -0.07 -0.01 -0.01 -0.04 -0.07 -0.11 -0.10 -0.06 -0.08 -0.10 -0.04 0.00 0.02 0.03 0.18 0.33 0.34 0.35 0.353
Sloan Accruals snapshot only 0.382
Cash Flow Adequacy snapshot only -4.073
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 1.7% 3.1% 4.6% 6.7% 3.5% 3.9% 4.2% 3.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.58 $0.59 $0.59 $0.59 $0.52 $0.50 $0.50 $0.51 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — 2.5% 0.0% 0.0% — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio — — — — — — — — — 36.5% 92.5% 0.0% 0.0% — — — — — — — —
Total Payout Ratio — — — — — — — — — — 2.8% 9.2% 77.4% — — 95.6% 7.1% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak — — — 0 0 0 0 0 0 0 0 — — — — — — — — — —
Chowder Number — — — — — — — -0.09 -0.08 -0.08 -0.09 — — — — — — — — — —
Buyback Yield 1.0% 0.5% 0.4% 0.0% 0.1% 1.0% 1.4% 2.0% 1.3% 0.5% 0.4% 0.3% 0.8% 1.2% 1.1% 1.4% 0.7% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 1.0% -10.5% -9.7% -10.6% -19.7% 1.0% 1.4% 2.0% 1.3% 0.5% 0.4% 0.2% 0.6% 1.1% 0.9% 1.4% 0.7% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 1.0% -10.5% -9.7% -8.9% -16.6% 5.7% 8.1% 5.5% 5.2% 4.7% 3.4% 0.2% 0.6% 1.1% 0.9% 1.4% 0.7% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.01 1.07 1.12 1.01 0.99 0.89 0.87 0.93 0.90 1.38 0.85 0.95 0.86 1.12 -0.54 0.83 0.87 0.87 0.88 0.88 0.878
Interest Burden (EBT/EBIT) 0.76 0.78 0.68 0.65 0.64 0.93 1.07 1.17 1.22 0.22 -1.04 5.75 -0.66 0.31 -0.05 -1.04 -9.15 -27.16 -47.94 -202.71 -202.710
EBIT Margin -0.88 -0.94 -0.93 -0.83 -0.88 -0.71 -0.71 -0.77 -0.37 -0.13 -0.05 0.02 -0.07 -0.20 -0.13 -0.07 -0.05 -0.03 -0.02 -0.00 -0.005
Asset Turnover 0.45 0.31 0.30 0.38 0.44 0.44 0.46 0.44 0.56 0.61 0.69 0.73 0.57 0.48 0.49 0.49 0.41 0.40 0.38 0.37 0.369
Equity Multiplier 1.62 1.36 1.43 1.43 1.54 1.38 1.50 1.50 1.58 1.58 1.72 1.72 1.68 1.68 1.71 1.71 1.54 1.54 1.49 1.49 1.490
Per Share
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.21 $-1.48 $-1.32 $-1.26 $-1.36 $-1.87 $-2.19 $-2.62 $-1.59 $-0.17 $0.21 $0.59 $0.17 $-0.24 $-0.01 $0.22 $1.45 $2.68 $2.69 $2.70 $2.70
Book Value/Share $2.96 $6.70 $5.76 $5.76 $4.71 $4.71 $3.61 $3.61 $4.51 $4.51 $4.29 $4.29 $4.24 $4.24 $4.35 $4.35 $7.04 $7.04 $7.22 $7.22 $7.36
Tangible Book/Share $2.96 $6.70 $5.76 $5.74 $4.71 $4.71 $3.61 $3.57 $4.51 $4.51 $4.29 $4.27 $4.24 $4.24 $4.35 $4.33 $7.04 $7.04 $7.22 $7.22 $7.22
Revenue/Share $1.78 $1.89 $1.85 $2.31 $2.44 $3.18 $3.27 $3.12 $4.00 $4.37 $4.68 $4.92 $4.15 $3.50 $3.55 $3.61 $3.53 $3.45 $3.32 $3.18 $3.17
FCF/Share $-0.66 $-0.80 $-0.99 $-1.29 $-1.44 $-1.76 $-1.94 $-2.12 $-1.18 $0.01 $0.55 $1.09 $0.35 $-0.37 $-0.24 $-0.10 $-0.19 $-0.28 $-0.36 $-0.43 $0.06
OCF/Share $-0.57 $-0.71 $-0.90 $-1.19 $-1.34 $-1.58 $-1.72 $-1.86 $-0.90 $0.27 $0.78 $1.29 $0.49 $-0.27 $-0.13 $0.00 $-0.09 $-0.19 $-0.27 $-0.35 $0.12
Cash/Share $2.74 $6.46 $5.92 $5.91 $4.88 $4.86 $3.75 $3.73 $4.95 $4.94 $5.21 $5.20 $4.60 $4.60 $4.80 $4.79 $7.83 $7.82 $7.88 $7.88 $7.95
EBITDA/Share $-1.52 $-1.74 $-1.69 $-1.88 $-2.10 $-2.20 $-2.28 $-2.36 $-1.41 $-0.53 $-0.19 $0.16 $-0.24 $-0.63 $-0.41 $-0.18 $-0.11 $-0.04 $0.01 $0.06 $0.06
Debt/Share $0.26 $0.25 $0.23 $0.23 $0.00 $0.00 $0.16 $0.16 $0.23 $0.23 $0.51 $0.51 $0.51 $0.51 $0.51 $0.51 $0.58 $0.54 $0.54 $0.54 $0.54
Net Debt/Share $-2.48 $-6.21 $-5.70 $-5.68 $-4.88 $-4.86 $-3.59 $-3.57 $-4.72 $-4.71 $-4.71 $-4.69 $-4.10 $-4.10 $-4.29 $-4.27 $-7.25 $-7.28 $-7.34 $-7.34 $-7.34
Academic Models
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.348
Altman Z-Prime snapshot only 8.412
Piotroski F-Score 4 3 4 5 5 4 4 4 4 6 7 7 5 0 1 3 4 4 6 6 6
Beneish M-Score -3.08 -2.32 -2.13 -7.61 -2.99 -2.05 -2.72 -3.47 -2.76 -2.42 0.69 0.61 -1.84 -1.61 -2.16 -2.29 -1.86 -1.26 -2.47 -2.48 -2.485
Ohlson O-Score snapshot only -10.261
ROIC (Greenblatt) snapshot only -0.19%
Net-Net WC snapshot only $6.25
Credit
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 75.55 76.00 76.00 76.00 76.00 65.50 49.15 59.65 61.00 70.90 76.75 87.75 79.75 69.55 75.55 70.15 73.00 73.00 67.00 61.00 61.000
Credit Grade snapshot only 8
Credit Trend snapshot only -9.150
Implied Spread (bps) snapshot only 225.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms